A detailed history of Public Employees Retirement System Of Ohio transactions in Castle Biosciences Inc stock. As of the latest transaction made, Public Employees Retirement System Of Ohio holds 93,436 shares of CSTL stock, worth $2.03 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
93,436
Previous 100,254 6.8%
Holding current value
$2.03 Million
Previous $2.16 Million 4.35%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$18.06 - $25.3 $123,133 - $172,495
-6,818 Reduced 6.8%
93,436 $2.07 Million
Q3 2023

Dec 19, 2023

BUY
$13.28 - $20.3 $248,057 - $379,183
18,679 Added 22.9%
100,254 $1.69 Million
Q3 2023

Nov 15, 2023

BUY
$13.28 - $20.3 $248,057 - $379,183
18,679 Added 22.9%
100,254 $1.69 Million
Q2 2023

Dec 19, 2023

BUY
$11.66 - $26.0 $173,384 - $386,620
14,870 Added 22.29%
81,575 $1.12 Million
Q2 2023

Aug 15, 2023

BUY
$11.66 - $26.0 $173,384 - $386,620
14,870 Added 22.29%
81,575 $1.12 Million
Q4 2022

Dec 19, 2023

SELL
$18.08 - $30.0 $606,565 - $1.01 Million
-33,549 Reduced 33.46%
66,705 $1.57 Million
Q4 2022

Feb 15, 2023

SELL
$18.08 - $30.0 $218,225 - $362,100
-12,070 Reduced 15.32%
66,705 $1.57 Million
Q3 2022

Nov 15, 2022

SELL
$22.51 - $34.32 $211,616 - $322,642
-9,401 Reduced 10.66%
78,775 $2.05 Million
Q1 2022

May 16, 2022

BUY
$33.17 - $46.98 $381,090 - $539,753
11,489 Added 14.98%
88,176 $3.96 Million
Q4 2021

Feb 15, 2022

BUY
$39.06 - $67.58 $798,112 - $1.38 Million
20,433 Added 36.32%
76,687 $3.29 Million
Q1 2021

May 14, 2021

BUY
$58.92 - $97.33 $830,889 - $1.37 Million
14,102 Added 33.46%
56,254 $3.85 Million
Q4 2020

Feb 12, 2021

BUY
$43.6 - $73.05 $1.84 Million - $3.08 Million
42,152 New
42,152 $2.83 Million

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $572M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Public Employees Retirement System Of Ohio Portfolio

Follow Public Employees Retirement System Of Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Employees Retirement System Of Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Public Employees Retirement System Of Ohio with notifications on news.